Tag Archives: Cancer Therapeutics CRC

Cancer Therapeutics CRC Deploys Surety's AbsoluteProof

Surety announced today that Cancer Therapeutics CRC Pty Ltd (CTx), an Australian pharmaceutical discovery and development company, has selected to use AbsoluteProof for its scientific IP protection. Focused solely on developing newly discovered drug compounds from cancer research considered ‘high risk’ … Read More »

Posted in: Compliance, Data Integrity, IP Protection, Surety News | 0 Comments